The trial, at Addenbrooke’s Hospital in Cambridge, tried to train the children’s immune systems to tolerate peanut protein by giving them a small amount of peanut protein powder, starting with a dose equivalent to one 70th of a peanut.
This amount was gradually increased every two weeks and after six months, 84% of the children were able eat the equivalent of five peanuts a day without triggering an allergic reaction.
These findings are published in the Lancet, but experts have warned that the therapy is not yet ready for widespread use.
Source: The Lancet
Subscribe to our newsletters
Every month Human Kinetics produces three unique email Newsletters, packed with great articles, events and news, plus information on our latest resources and exclusive reader offers. They’re completely free and if you change your mind you can unsubscribe at any time. So subscribe today.
Fill in your information below and check the emails you want.